The assay will be featured at the San Antonio Breast Cancer Symposium, offering a highly sensitive detection method using qPCR technology. This ...
News
- Bio-Techne Corp (TECH) Launches Innovative ESR1 Mutation Monitoring Assay
- BioNTech's overall survival data show promise of potential Keytruda killer in breast cancer
The German biotech ... Researchers shared the first look at OS data from the Chinese trial at the San Antonio Breast Cancer Symposium Tuesday.
- UTSA's Stanton F. McHardy named fellow of National Academy of Inventors | UTSA Today
The CIDD is a collaborative initiative between UTSA and UT Health San Antonio. “I feel extremely honored to be included as an NAI fellow and have the ...
- Myriad Genetics to Present New Data at San Antonio Breast Cancer Symposium - BioSpace
(NASDAQ: MYGN), a leader in genetic testing and precision medicine, announced it will present new data at the 2024 San Antonio Breast Cancer ...
- Richmond-based BioAge sees stock fall over 70% after halting obesity drug clinical trial
San Antonio · San Francisco · Seattle · Silicon Valley · St. Louis · Tampa Bay ... Bay Area biotech sells cancer drug for over $400 million. Related ...